NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral …
Daily Archives
June 4, 2025
-
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796
by Asia Insider -
SASKATOON, Saskatchewan, June 04, 2025 (GLOBE NEWSWIRE) — A ceremony will be held at MADD …
-
Ivan Espinosa, chief executive officer of Nissan Motor Co., speaks during an interview at the …
-
Electric vehicles outside a Tesla dealership in Melbourne on April 19, 2023. William West | …
-
Vietnam is preparing to open the door to regulated cryptocurrency exchanges—but only for well-capitalized, institutional-grade …
-
Vietnam’s equity market is riding a wave of optimism, with experts forecasting a potential return …
-
Australia’s first-quarter economic growth misses estimates, expanding 1.3% from a year earlier
by Asia InsiderSydney Harbour and the skyline of the central business district (CBD) in Sydney, Australia, on …